Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NIH × Carcinoma, Basal Cell × Clear all

Phase

Phase 2 6 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

OTHER 68 INDUSTRY 13 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Prostatic Neoplasms 17 Lung Neoplasms 15 Lymphoma 14 Carcinoma, Non-Small-Cell Lung 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Rectal Neoplasms 12 Leukemia 12 Neoplasms 11 Uterine Cervical Neoplasms 10 Unspecified Adult Solid Tumor, Protocol Specific 10 Colorectal Neoplasms 10 Colonic Neoplasms 10 Sarcoma 9 Central Nervous System Neoplasms 8 Brain Neoplasms 8 Pain 7 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Head and Neck Neoplasms 7 Small Cell Lung Carcinoma 6 Neuroblastoma 6 Myelodysplastic Syndromes 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Ovarian Epithelial 6 Testicular Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Glioblastoma 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00025012 2013-06-19

Isotretinoin in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase NA Completed

Carcinoma, Basal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡